Viewing Study NCT00499369


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-05-16 @ 9:33 AM
Study NCT ID: NCT00499369
Status: TERMINATED
Last Update Posted: 2014-07-31
First Post: 2007-07-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Colon Cancer View
None Recurrent Rectal Cancer View
None Stage IVA Colon Cancer View
None Stage IVA Rectal Cancer View
None Stage IVB Colon Cancer View
None Stage IVB Rectal Cancer View
Keywords: